🦥 Unsloth: Will patch your computer to enable 2x faster free finetuning.
Unsloth: Failed to patch Gemma3ForConditionalGeneration.
🦥 Unsloth Zoo will now patch everything to make training faster!
INFO 04-10 18:37:22 [__init__.py:239] Automatically detected platform cuda.
==((====))==  Unsloth 2025.3.19: Fast Llama patching. Transformers: 4.51.1. vLLM: 0.8.3.
   \\   /|    Tesla V100-PCIE-32GB. Num GPUs = 1. Max memory: 31.739 GB. Platform: Linux.
O^O/ \_/ \    Torch: 2.6.0+cu124. CUDA: 7.0. CUDA Toolkit: 12.4. Triton: 3.2.0
\        /    Bfloat16 = FALSE. FA [Xformers = 0.0.29.post3. FA2 = False]
 "-____-"     Free license: http://github.com/unslothai/unsloth
Unsloth: Fast downloading is enabled - ignore downloading bars which are red colored!
Unsloth: Your GPU does not support prefix caching - will disable!
Unsloth: vLLM loading /home/u111169/wrkdir/mgh-project/models/models--meta-llama--Llama-3.1-8B-Instruct/snapshots/0e9e39f249a16976918f6564b8830bc894c89659 with actual GPU utilization = 59.35%
Unsloth: Your GPU has CUDA compute capability 7.0 with VRAM = 31.74 GB.
Unsloth: Using conservativeness = 1.0. Chunked prefill tokens = 5000. Num Sequences = 160.
Unsloth: vLLM's KV Cache can use up to 3.84 GB. Also swap space = 6 GB.
WARNING 04-10 18:37:25 [config.py:2704] Casting torch.bfloat16 to torch.float16.
INFO 04-10 18:37:33 [config.py:600] This model supports multiple tasks: {'embed', 'score', 'classify', 'generate', 'reward'}. Defaulting to 'generate'.
WARNING 04-10 18:37:33 [arg_utils.py:1708] Compute Capability < 8.0 is not supported by the V1 Engine. Falling back to V0. 
Unsloth: vLLM Bitsandbytes config using kwargs = {'load_in_8bit': False, 'load_in_4bit': True, 'bnb_4bit_compute_dtype': 'float16', 'bnb_4bit_quant_storage': 'uint8', 'bnb_4bit_quant_type': 'fp4', 'bnb_4bit_use_double_quant': False, 'llm_int8_enable_fp32_cpu_offload': False, 'llm_int8_has_fp16_weight': False, 'llm_int8_skip_modules': [], 'llm_int8_threshold': 6.0}
INFO 04-10 18:37:33 [llm_engine.py:242] Initializing a V0 LLM engine (v0.8.3) with config: model='/home/u111169/wrkdir/mgh-project/models/models--meta-llama--Llama-3.1-8B-Instruct/snapshots/0e9e39f249a16976918f6564b8830bc894c89659', speculative_config=None, tokenizer='/home/u111169/wrkdir/mgh-project/models/models--meta-llama--Llama-3.1-8B-Instruct/snapshots/0e9e39f249a16976918f6564b8830bc894c89659', skip_tokenizer_init=False, tokenizer_mode=auto, revision=None, override_neuron_config=None, tokenizer_revision=None, trust_remote_code=False, dtype=torch.float16, max_seq_len=5000, download_dir=None, load_format=LoadFormat.BITSANDBYTES, tensor_parallel_size=1, pipeline_parallel_size=1, disable_custom_all_reduce=False, quantization=bitsandbytes, enforce_eager=False, kv_cache_dtype=auto,  device_config=cuda:0, decoding_config=DecodingConfig(guided_decoding_backend='xgrammar', reasoning_backend=None), observability_config=ObservabilityConfig(show_hidden_metrics=False, otlp_traces_endpoint=None, collect_model_forward_time=False, collect_model_execute_time=False), seed=0, served_model_name=/home/u111169/wrkdir/mgh-project/models/models--meta-llama--Llama-3.1-8B-Instruct/snapshots/0e9e39f249a16976918f6564b8830bc894c89659, num_scheduler_steps=1, multi_step_stream_outputs=True, enable_prefix_caching=False, chunked_prefill_enabled=False, use_async_output_proc=True, disable_mm_preprocessor_cache=False, mm_processor_kwargs=None, pooler_config=None, compilation_config={"level":0,"splitting_ops":[],"compile_sizes":[],"cudagraph_capture_sizes":[160,152,144,136,128,120,112,104,96,88,80,72,64,56,48,40,32,24,16,8,4,2,1],"max_capture_size":160}, use_cached_outputs=False, 
/share/apps/eb/Python/3.11.5-GCCcore-13.2.0/envs/vllm/lib/python3.11/site-packages/vllm/executor/uniproc_executor.py:29: UserWarning: Failed to get the IP address, using 0.0.0.0 by default.The value can be set by the environment variable VLLM_HOST_IP or HOST_IP.
  get_ip(), get_open_port())
INFO 04-10 18:37:34 [cuda.py:240] Cannot use FlashAttention-2 backend for Volta and Turing GPUs.
INFO 04-10 18:37:34 [cuda.py:289] Using XFormers backend.
[W410 18:37:34.263231243 socket.cpp:204] [c10d] The hostname of the client socket cannot be retrieved. err=-3
[W410 18:37:34.263483113 socket.cpp:204] [c10d] The hostname of the client socket cannot be retrieved. err=-3
INFO 04-10 18:37:34 [parallel_state.py:957] rank 0 in world size 1 is assigned as DP rank 0, PP rank 0, TP rank 0
INFO 04-10 18:37:34 [model_runner.py:1110] Starting to load model /home/u111169/wrkdir/mgh-project/models/models--meta-llama--Llama-3.1-8B-Instruct/snapshots/0e9e39f249a16976918f6564b8830bc894c89659...
INFO 04-10 18:37:34 [loader.py:1155] Loading weights with BitsAndBytes quantization. May take a while ...
Loading safetensors checkpoint shards:   0% Completed | 0/4 [00:00<?, ?it/s]
Loading safetensors checkpoint shards:  25% Completed | 1/4 [00:22<01:07, 22.58s/it]
Loading safetensors checkpoint shards:  50% Completed | 2/4 [01:54<02:07, 63.55s/it]
Loading safetensors checkpoint shards:  75% Completed | 3/4 [03:16<01:11, 71.72s/it]
Loading safetensors checkpoint shards: 100% Completed | 4/4 [04:44<00:00, 78.14s/it]
Loading safetensors checkpoint shards: 100% Completed | 4/4 [04:44<00:00, 71.06s/it]

INFO 04-10 18:42:19 [punica_selector.py:18] Using PunicaWrapperGPU.
INFO 04-10 18:42:19 [model_runner.py:1146] Model loading took 5.4012 GiB and 284.460362 seconds
INFO 04-10 18:42:28 [worker.py:267] Memory profiling takes 8.80 seconds
INFO 04-10 18:42:28 [worker.py:267] the current vLLM instance can use total_gpu_memory (31.74GiB) x gpu_memory_utilization (0.59) = 18.84GiB
INFO 04-10 18:42:28 [worker.py:267] model weights take 5.40GiB; non_torch_memory takes 0.07GiB; PyTorch activation peak memory takes 0.77GiB; the rest of the memory reserved for KV Cache is 12.59GiB.
INFO 04-10 18:42:28 [executor_base.py:112] # cuda blocks: 6448, # CPU blocks: 3072
INFO 04-10 18:42:28 [executor_base.py:117] Maximum concurrency for 5000 tokens per request: 20.63x
INFO 04-10 18:42:31 [model_runner.py:1456] Capturing cudagraphs for decoding. This may lead to unexpected consequences if the model is not static. To run the model in eager mode, set 'enforce_eager=True' or use '--enforce-eager' in the CLI. If out-of-memory error occurs during cudagraph capture, consider decreasing `gpu_memory_utilization` or switching to eager mode. You can also reduce the `max_num_seqs` as needed to decrease memory usage.
Capturing CUDA graph shapes:   0%|          | 0/23 [00:00<?, ?it/s]Capturing CUDA graph shapes:   4%|▍         | 1/23 [00:01<00:35,  1.60s/it]Capturing CUDA graph shapes:   9%|▊         | 2/23 [00:03<00:31,  1.51s/it]Capturing CUDA graph shapes:  13%|█▎        | 3/23 [00:04<00:29,  1.49s/it]Capturing CUDA graph shapes:  17%|█▋        | 4/23 [00:05<00:28,  1.48s/it]Capturing CUDA graph shapes:  22%|██▏       | 5/23 [00:07<00:25,  1.42s/it]Capturing CUDA graph shapes:  26%|██▌       | 6/23 [00:08<00:23,  1.40s/it]Capturing CUDA graph shapes:  30%|███       | 7/23 [00:09<00:22,  1.38s/it]Capturing CUDA graph shapes:  35%|███▍      | 8/23 [00:11<00:20,  1.36s/it]Capturing CUDA graph shapes:  39%|███▉      | 9/23 [00:12<00:18,  1.34s/it]Capturing CUDA graph shapes:  43%|████▎     | 10/23 [00:13<00:17,  1.33s/it]Capturing CUDA graph shapes:  48%|████▊     | 11/23 [00:15<00:15,  1.32s/it]Capturing CUDA graph shapes:  52%|█████▏    | 12/23 [00:16<00:14,  1.32s/it]Capturing CUDA graph shapes:  57%|█████▋    | 13/23 [00:17<00:12,  1.27s/it]Capturing CUDA graph shapes:  61%|██████    | 14/23 [00:18<00:11,  1.23s/it]Capturing CUDA graph shapes:  65%|██████▌   | 15/23 [00:20<00:09,  1.21s/it]Capturing CUDA graph shapes:  70%|██████▉   | 16/23 [00:21<00:08,  1.19s/it]Capturing CUDA graph shapes:  74%|███████▍  | 17/23 [00:22<00:07,  1.19s/it]Capturing CUDA graph shapes:  78%|███████▊  | 18/23 [00:23<00:05,  1.18s/it]Capturing CUDA graph shapes:  83%|████████▎ | 19/23 [00:24<00:04,  1.18s/it]Capturing CUDA graph shapes:  87%|████████▋ | 20/23 [00:25<00:03,  1.18s/it]Capturing CUDA graph shapes:  91%|█████████▏| 21/23 [00:26<00:02,  1.17s/it]Capturing CUDA graph shapes:  96%|█████████▌| 22/23 [00:28<00:01,  1.16s/it]Capturing CUDA graph shapes: 100%|██████████| 23/23 [00:28<00:00,  1.04s/it]Capturing CUDA graph shapes: 100%|██████████| 23/23 [00:28<00:00,  1.26s/it]
INFO 04-10 18:43:00 [model_runner.py:1598] Graph capturing finished in 29 secs, took 3.07 GiB
INFO 04-10 18:43:00 [llm_engine.py:448] init engine (profile, create kv cache, warmup model) took 40.87 seconds
/home/u111169/wrkdir/mgh-project/models/models--meta-llama--Llama-3.1-8B-Instruct/snapshots/0e9e39f249a16976918f6564b8830bc894c89659 does not have a padding token! Will use pad_token = <|finetune_right_pad_id|>.
Unsloth 2025.3.19 patched 32 layers with 32 QKV layers, 32 O layers and 32 MLP layers.
Map:   0%|          | 0/2497 [00:00<?, ? examples/s]Map:  62%|██████▏   | 1536/2497 [00:00<00:00, 15274.43 examples/s]Map: 100%|██████████| 2497/2497 [00:00<00:00, 14367.17 examples/s]
Unsloth: We now expect `per_device_train_batch_size` to be a multiple of `num_generations`.
We will change the batch size of 1 to the `num_generations` of 4
WARNING:accelerate.utils.other:Detected kernel version 5.3.18, which is below the recommended minimum of 5.5.0; this can cause the process to hang. It is recommended to upgrade the kernel to the minimum version or higher.
==((====))==  Unsloth - 2x faster free finetuning | Num GPUs used = 1
   \\   /|    Num examples = 2,497 | Num Epochs = 1 | Total steps = 250
O^O/ \_/ \    Batch size per device = 4 | Gradient accumulation steps = 1
\        /    Data Parallel GPUs = 1 | Total batch size (4 x 1 x 1) = 4
 "-____-"     Trainable parameters = 20,971,520/8,000,000,000 (0.26% trained)
  0%|          | 0/250 [00:00<?, ?it/s]-------------------- Question:

            I have developed a model that can predict the drug likelibility of compound X.
            This model outputs two lists:
            1. The five most similar approved small molecules (with their properties and similarity scores).
            2. The five most similar non-approved small molecules (with their properties and similarity scores).

            Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.

            - RDKit Analysis of Compound X:
            {'Molecular Weight': 263.38, 'LogP': 2.63, 'Molecular Refractivity': 77.4, 'TPSA': 32.7, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 4, 'Chiral Centers': 2, 'Heavy Atoms': 19, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}

            Using the provided data:
            {'most similar appoved drugs': {1: { 'similarity score': 0.99, 'Rdkit information': {'Molecular Weight': 263.38, 'LogP': 2.63, 'Molecular Refractivity': 77.4, 'TPSA': 32.70, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 4, 'Chiral Centers': 0, 'Heavy Atoms': 19, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}, 2: { 'similarity score': 0.98, 'Rdkit information': {'Molecular Weight': 299.84, 'LogP': 3.06, 'Molecular Refractivity': 84.65, 'TPSA': 32.70, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 4, 'Chiral Centers': 0, 'Heavy Atoms': 20, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.95, 'Rdkit information': {'Molecular Weight': 237.73, 'LogP': 2.9, 'Molecular Refractivity': 65.66, 'TPSA': 29.10, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 2, 'Rotatable Bonds': 2, 'Chiral Centers': 0, 'Heavy Atoms': 16, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}, 4: { 'similarity score': 0.94, 'Rdkit information': {'Molecular Weight': 309.41, 'LogP': 3.42, 'Molecular Refractivity': 93.94, 'TPSA': 30.29, 'Hydrogen Bond_Donors': 0, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 7, 'Chiral Centers': 0, 'Heavy Atoms': 23, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['Aliphatic_long_chain']}}, 5: { 'similarity score': 0.94, 'Rdkit information': {'Molecular Weight': 264.37, 'LogP': 2.62, 'Molecular Refractivity': 78.68, 'TPSA': 41.57, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 8, 'Chiral Centers': 0, 'Heavy Atoms': 19, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['Aliphatic_long_chain']}}}, 'most similar non appoved drugs': {1: { 'similarity score': 0.92, 'Rdkit information': {'Molecular Weight': 281.42, 'LogP': 2.68, 'Molecular Refractivity': 78.26, 'TPSA': 37.38, 'Hydrogen Bond_Donors': 0, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 4, 'Chiral Centers': 0, 'Heavy Atoms': 19, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}, 2: { 'similarity score': 0.92, 'Rdkit information': {'Molecular Weight': 315.84, 'LogP': 4.38, 'Molecular Refractivity': 94.71, 'TPSA': 12.47, 'Hydrogen Bond_Donors': 0, 'Hydrogen_Bond Acceptors': 2, 'Rotatable Bonds': 3, 'Chiral Centers': 0, 'Heavy Atoms': 22, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.92, 'Rdkit information': {'Molecular Weight': 341.45, 'LogP': 3.24, 'Molecular Refractivity': 100.2, 'TPSA': 58.56, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 11, 'Chiral Centers': 1, 'Heavy Atoms': 25, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': ['Aliphatic_long_chain']}}, 4: { 'similarity score': 0.92, 'Rdkit information': {'Molecular Weight': 295.85, 'LogP': 4.17, 'Molecular Refractivity': 85.5, 'TPSA': 12.47, 'Hydrogen Bond_Donors': 0, 'Hydrogen_Bond Acceptors': 2, 'Rotatable Bonds': 8, 'Chiral Centers': 0, 'Heavy Atoms': 20, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': ['Aliphatic_long_chain']}}, 5: { 'similarity score': 0.91, 'Rdkit information': {'Molecular Weight': 313.87, 'LogP': 4.59, 'Molecular Refractivity': 97.79, 'TPSA': 3.24, 'Hydrogen Bond_Donors': 0, 'Hydrogen_Bond Acceptors': 1, 'Rotatable Bonds': 3, 'Chiral Centers': 0, 'Heavy Atoms': 22, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['styrene_A(13)']}}}}
             
Answer:
<APPROVED> 
Response:
</reasoning>
To assess the likelihood of compound X receiving regulatory approval, we need to analyze its similarity to known approved and non-approved molecules.

First, let's calculate a drug-likeness score for each of the five most similar approved and non-approved drugs. We'll use a weighted average of the properties, assuming equal weights for simplicity.

For approved drugs:
- Molecular Weight: (263.38 + 299.84 + 237.73 + 309.41 + 264.37) / 5 = 264.89
- LogP: (2.63 + 3.06 + 2.9 + 3.42 + 2.62) / 5 = 2.98
- Molecular Refractivity: (77.4 + 84.65 + 65.66 + 93.94 + 78.68) / 5 = 79.31
- TPSA: (32.7 + 32.7 + 29.1 + 30.29 + 41.57) / 5 = 32.63
- Hydrogen Bond_Donors: (1 + 1 + 1 + 0 + 1) / 5 = 0.8
- Hydrogen_Bond Acceptors: (3 + 3 + 2 + 4 + 4) / 5 = 3.2
- Rotatable Bonds: (4 + 4 + 2 + 7 + 8) / 5 = 4.6
- Chiral Centers: (0 + 0 + 0 + 0 + 0) / 5 = 0
- Heavy Atoms: (19 + 20 + 16 + 23 + 19) / 5 = 19.6
- Formal Charge: (0 + 0 + 0 + 0 + 0) / 5 = 0
- Total Rings: (2 + 2 + 2 + 3 + 1) / 5 = 1.8
- Structural Alerts: Assume all approved drugs have no structural alerts

For non-approved drugs:
- Molecular Weight: (281.42 + 315.84 + 341.45 + 295.85 + 313.87) / 5 = 307.82
- LogP: (2.68 + 4.38 + 3.24 + 4.17 + 4.59) / 5 = 3.72
- Molecular Refractivity: (78.26 + 94.71 + 100.2 + 85.5 + 97.79) / 5 = 90.34
- TPSA: (37.38 + 12.47 + 58.56 + 12.47 + 3.24) / 5 = 24.57
- Hydrogen Bond_Donors: (0 + 0 + 2 + 0 + 0) / 5 = 0.4
- Hydrogen_Bond Acceptors: (3 + 2 + 4 + 2 + 1) / 5 = 2.4
- Rotatable Bonds: (4 + 3 + 11 + 8 + 3) / 5 = 5.6
- Chiral Centers: (0 + 0 + 1 + 0 + 0) / 5 = 0.2
- Heavy Atoms: (19 + 22 + 25 + 20 + 22) / 5 = 21.6
- Formal Charge: (0 + 0 + 0 + 0 + 0) / 5 = 0
- Total Rings: (2 + 3 + 2 + 2 + 3) / 5 = 2.4
- Structural Alerts: Assume non-approved drugs have at least one structural alert each

Next, let's calculate the overall similarity score for each set of drugs. We'll use the weighted average of the similarity scores, with weights corresponding to the number of similar properties between compound X and each molecule.

Approved drugs: 0.99*0.98 + 0.98*0.95 + 0.95*0.94 + 0.94*0.94 + 0.94*0.98 = 0.949
Non-approved drugs: 0.92*0.92 + 0.92*0.92 + 0.92*0.92 + 0.92*0.91 + 0.91*0.91 = 0.907

Finally, let's compare the overall similarity scores to assess the likelihood of compound X receiving regulatory approval.

Based on the similarity scores, it appears that compound X is more similar to approved drugs, with a score of 0.949, than it is to non-approved drugs, with a score of 0.907. This suggests that compound X has a higher likelihood of being approved.

However, the actual likelihood of approval depends on many factors, including the specific regulatory requirements for the desired indication and the results of further preclinical and clinical trials. Therefore, we need to be cautious when making predictions based on similarity scores alone.

</answer>

Drug-likeness score for approved molecules: 0.949
Drug-likeness score for non-approved molecules: 0.907
Likelihood of compound X receiving regulatory approval: High 
Extracted:
</reasoning>
To assess the likelihood of compound X receiving regulatory approval, we need to analyze its similarity to known approved and non-approved molecules.

First, let's calculate a drug-likeness score for each of the five most similar approved and non-approved drugs. We'll use a weighted average of the properties, assuming equal weights for simplicity.

For approved drugs:
- Molecular Weight: (263.38 + 299.84 + 237.73 + 309.41 + 264.37) / 5 = 264.89
- LogP: (2.63 + 3.06 + 2.9 + 3.42 + 2.62) / 5 = 2.98
- Molecular Refractivity: (77.4 + 84.65 + 65.66 + 93.94 + 78.68) / 5 = 79.31
- TPSA: (32.7 + 32.7 + 29.1 + 30.29 + 41.57) / 5 = 32.63
- Hydrogen Bond_Donors: (1 + 1 + 1 + 0 + 1) / 5 = 0.8
- Hydrogen_Bond Acceptors: (3 + 3 + 2 + 4 + 4) / 5 = 3.2
- Rotatable Bonds: (4 + 4 + 2 + 7 + 8) / 5 = 4.6
- Chiral Centers: (0 + 0 + 0 + 0 + 0) / 5 = 0
- Heavy Atoms: (19 + 20 + 16 + 23 + 19) / 5 = 19.6
- Formal Charge: (0 + 0 + 0 + 0 + 0) / 5 = 0
- Total Rings: (2 + 2 + 2 + 3 + 1) / 5 = 1.8
- Structural Alerts: Assume all approved drugs have no structural alerts

For non-approved drugs:
- Molecular Weight: (281.42 + 315.84 + 341.45 + 295.85 + 313.87) / 5 = 307.82
- LogP: (2.68 + 4.38 + 3.24 + 4.17 + 4.59) / 5 = 3.72
- Molecular Refractivity: (78.26 + 94.71 + 100.2 + 85.5 + 97.79) / 5 = 90.34
- TPSA: (37.38 + 12.47 + 58.56 + 12.47 + 3.24) / 5 = 24.57
- Hydrogen Bond_Donors: (0 + 0 + 2 + 0 + 0) / 5 = 0.4
- Hydrogen_Bond Acceptors: (3 + 2 + 4 + 2 + 1) / 5 = 2.4
- Rotatable Bonds: (4 + 3 + 11 + 8 + 3) / 5 = 5.6
- Chiral Centers: (0 + 0 + 1 + 0 + 0) / 5 = 0.2
- Heavy Atoms: (19 + 22 + 25 + 20 + 22) / 5 = 21.6
- Formal Charge: (0 + 0 + 0 + 0 + 0) / 5 = 0
- Total Rings: (2 + 3 + 2 + 2 + 3) / 5 = 2.4
- Structural Alerts: Assume non-approved drugs have at least one structural alert each

Next, let's calculate the overall similarity score for each set of drugs. We'll use the weighted average of the similarity scores, with weights corresponding to the number of similar properties between compound X and each molecule.

Approved drugs: 0.99*0.98 + 0.98*0.95 + 0.95*0.94 + 0.94*0.94 + 0.94*0.98 = 0.949
Non-approved drugs: 0.92*0.92 + 0.92*0.92 + 0.92*0.92 + 0.92*0.91 + 0.91*0.91 = 0.907

Finally, let's compare the overall similarity scores to assess the likelihood of compound X receiving regulatory approval.

Based on the similarity scores, it appears that compound X is more similar to approved drugs, with a score of 0.949, than it is to non-approved drugs, with a score of 0.907. This suggests that compound X has a higher likelihood of being approved.

However, the actual likelihood of approval depends on many factors, including the specific regulatory requirements for the desired indication and the results of further preclinical and clinical trials. Therefore, we need to be cautious when making predictions based on similarity scores alone.
  0%|          | 1/250 [02:36<10:48:45, 156.33s/it]                                                   {'loss': 0.0, 'grad_norm': 0.1615755707025528, 'learning_rate': 0.0, 'rewards/xmlcount_reward_func': -0.8849999904632568, 'rewards/soft_format_reward_func': 0.0, 'rewards/strict_format_reward_func': 0.0, 'rewards/int_reward_func': 0.0, 'rewards/correctness_reward_func': 0.0, 'reward': -0.8849999904632568, 'reward_std': 0.9366728663444519, 'completion_length': 557.0, 'kl': 0.0, 'epoch': 0.0}
  0%|          | 1/250 [02:36<10:48:45, 156.33s/it]-------------------- Question:

            I have developed a model that can predict the drug likelibility of compound X.
            This model outputs two lists:
            1. The five most similar approved small molecules (with their properties and similarity scores).
            2. The five most similar non-approved small molecules (with their properties and similarity scores).

            Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.

            - RDKit Analysis of Compound X:
            {'Molecular Weight': 1486.57, 'LogP': -7.85, 'Molecular Refractivity': 364.21, 'TPSA': 488.88, 'Hydrogen Bond_Donors': 14, 'Hydrogen_Bond Acceptors': 25, 'Rotatable Bonds': 26, 'Chiral Centers': 10, 'Heavy Atoms': 100, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': ['Aliphatic_long_chain', 'disulphide']}

            Using the provided data:
            {'most similar appoved drugs': {1: { 'similarity score': 0.88, 'Rdkit information': {'Molecular Weight': 1500.55, 'LogP': -7.76, 'Molecular Refractivity': 364.76, 'TPSA': 505.95, 'Hydrogen Bond_Donors': 14, 'Hydrogen_Bond Acceptors': 25, 'Rotatable Bonds': 26, 'Chiral Centers': 10, 'Heavy Atoms': 101, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': ['Aliphatic_long_chain', 'disulphide']}}, 2: { 'similarity score': 0.78, 'Rdkit information': {'Molecular Weight': 1394.59, 'LogP': -3.4, 'Molecular Refractivity': 355.87, 'TPSA': 494.22, 'Hydrogen Bond_Donors': 17, 'Hydrogen_Bond Acceptors': 21, 'Rotatable Bonds': 34, 'Chiral Centers': 10, 'Heavy Atoms': 97, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': ['Aliphatic_long_chain', 'disulphide']}}, 3: { 'similarity score': 0.77, 'Rdkit information': {'Molecular Weight': 511.51, 'LogP': -3.37, 'Molecular Refractivity': 120.12, 'TPSA': 225.76, 'Hydrogen Bond_Donors': 5, 'Hydrogen_Bond Acceptors': 12, 'Rotatable Bonds': 10, 'Chiral Centers': 1, 'Heavy Atoms': 35, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['aldehyde']}}, 4: { 'similarity score': 0.73, 'Rdkit information': {'Molecular Weight': 473.45, 'LogP': -0.73, 'Molecular Refractivity': 120.78, 'TPSA': 219.84, 'Hydrogen Bond_Donors': 7, 'Hydrogen_Bond Acceptors': 9, 'Rotatable Bonds': 10, 'Chiral Centers': 1, 'Heavy Atoms': 34, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['aldehyde']}}, 5: { 'similarity score': 0.72, 'Rdkit information': {'Molecular Weight': 681.75, 'LogP': -4.68, 'Molecular Refractivity': 119.85, 'TPSA': 213.94, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 12, 'Rotatable Bonds': 20, 'Chiral Centers': 1, 'Heavy Atoms': 38, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': 'None'}}}, 'most similar non appoved drugs': {1: { 'similarity score': 0.89, 'Rdkit information': {'Molecular Weight': 1609.57, 'LogP': -7.38, 'Molecular Refractivity': 359.0, 'TPSA': 505.95, 'Hydrogen Bond_Donors': 14, 'Hydrogen_Bond Acceptors': 25, 'Rotatable Bonds': 26, 'Chiral Centers': 10, 'Heavy Atoms': 101, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': ['Aliphatic_long_chain', 'disulphide']}}, 2: { 'similarity score': 0.75, 'Rdkit information': {'Molecular Weight': 573.67, 'LogP': -0.46, 'Molecular Refractivity': 150.45, 'TPSA': 199.95, 'Hydrogen Bond_Donors': 7, 'Hydrogen_Bond Acceptors': 8, 'Rotatable Bonds': 16, 'Chiral Centers': 3, 'Heavy Atoms': 40, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.73, 'Rdkit information': {'Molecular Weight': 473.45, 'LogP': -0.73, 'Molecular Refractivity': 120.78, 'TPSA': 219.84, 'Hydrogen Bond_Donors': 7, 'Hydrogen_Bond Acceptors': 9, 'Rotatable Bonds': 10, 'Chiral Centers': 2, 'Heavy Atoms': 34, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['aldehyde']}}, 4: { 'similarity score': 0.71, 'Rdkit information': {'Molecular Weight': 752.23, 'LogP': -0.18, 'Molecular Refractivity': 179.0, 'TPSA': 256.90, 'Hydrogen Bond_Donors': 6, 'Hydrogen_Bond Acceptors': 14, 'Rotatable Bonds': 13, 'Chiral Centers': 2, 'Heavy Atoms': 50, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': ['catechol_A(92)', 'catechol', 'imine_1', 'Oxygen-nitrogen_single_bond', 'quaternary_nitrogen_2']}}, 5: { 'similarity score': 0.71, 'Rdkit information': {'Molecular Weight': 588.67, 'LogP': -1.97, 'Molecular Refractivity': 151.75, 'TPSA': 235.91, 'Hydrogen Bond_Donors': 8, 'Hydrogen_Bond Acceptors': 7, 'Rotatable Bonds': 9, 'Chiral Centers': 4, 'Heavy Atoms': 42, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': ['Aliphatic_long_chain', 'imine_1', 'imine_2']}}}}
             
Answer:
<NOT APPROVED> 
Response:
## Analysis

To determine the likelihood of compound X receiving regulatory approval, we will analyze its similarity to both approved and non-approved small molecules.

### Similarity to Approved Small Molecules

The model has identified the top 5 most similar approved small molecules to compound X, with their respective similarity scores:

1. {'similarity score': 0.88, 'Rdkit information': {'Molecular Weight': 1500.55, 'LogP': -7.76, 'Molecular Refractivity': 364.76, 'TPSA': 505.95, 'Hydrogen Bond_Donors': 14, 'Hydrogen_Bond Acceptors': 25, 'Rotatable Bonds': 26, 'Chiral Centers': 10, 'Heavy Atoms': 101, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': ['Aliphatic_long_chain', 'disulphide']}}
2. {'similarity score': 0.78, 'Rdkit information': {'Molecular Weight': 1394.59, 'LogP': -3.4, 'Molecular Refractivity': 355.87, 'TPSA': 494.22, 'Hydrogen Bond_Donors': 17, 'Hydrogen_Bond Acceptors': 21, 'Rotatable Bonds': 34, 'Chiral Centers': 10, 'Heavy Atoms': 97, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': ['Aliphatic_long_chain', 'disulphide']}}
3. {'similarity score': 0.77, 'Rdkit information': {'Molecular Weight': 511.51, 'LogP': -3.37, 'Molecular Refractivity': 120.12, 'TPSA': 225.76, 'Hydrogen Bond_Donors': 5, 'Hydrogen_Bond Acceptors': 12, 'Rotatable Bonds': 10, 'Chiral Centers': 1, 'Heavy Atoms': 35, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['aldehyde']}}
4. {'similarity score': 0.73, 'Rdkit information': {'Molecular Weight': 473.45, 'LogP': -0.73, 'Molecular Refractivity': 120.78, 'TPSA': 219.84, 'Hydrogen Bond_Donors': 7, 'Hydrogen_Bond Acceptors': 9, 'Rotatable Bonds': 10, 'Chiral Centers': 1, 'Heavy Atoms': 34, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['aldehyde']}}
5. {'similarity score': 0.72, 'Rdkit information': {'Molecular Weight': 681.75, 'LogP': -4.68, 'Molecular Refractivity': 119.85, 'TPSA': 213.94, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 12, 'Rotatable Bonds': 20, 'Chiral Centers': 1, 'Heavy Atoms': 38, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': 'None'}}

### Similarity to Non-Approved Small Molecules

The model has identified the top 5 most similar non-approved small molecules to compound X, with their respective similarity scores:

1. {'similarity score': 0.89, 'Rdkit information': {'Molecular Weight': 1609.57, 'LogP': -7.38, 'Molecular Refractivity': 359.0, 'TPSA': 505.95, 'Hydrogen Bond_Donors': 14, 'Hydrogen_Bond Acceptors': 25, 'Rotatable Bonds': 26, 'Chiral Centers': 10, 'Heavy Atoms': 101, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': ['Aliphatic_long_chain', 'disulphide']}}
2. {'similarity score': 0.75, 'Rdkit information': {'Molecular Weight': 573.67, 'LogP': -0.46, 'Molecular Refractivity': 150.45, 'TPSA': 199.95, 'Hydrogen Bond_Donors': 7, 'Hydrogen_Bond Acceptors': 8, 'Rotatable Bonds': 16, 'Chiral Centers': 3, 'Heavy Atoms': 40, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}
3. {'similarity score': 0.73, 'Rdkit information': {'Molecular Weight': 473.45, 'LogP': -0.73, 'Molecular Refractivity': 120.78, 'TPSA': 219.84, 'Hydrogen Bond_Donors': 7, 'Hydrogen_Bond Acceptors': 9, 'Rotatable Bonds': 10, 'Chiral Centers': 2, 'Heavy Atoms': 34, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['aldehyde']}}
4. {'similarity score': 0.71, 'Rdkit information': {'Molecular Weight': 752.23, 'LogP': -0.18, 'Molecular Refractivity': 179.0, 'TPSA': 256.90, 'Hydrogen Bond_Donors': 6, 'Hydrogen_Bond Acceptors': 14, 'Rotatable Bonds': 13, 'Chiral Centers': 2, 'Heavy Atoms': 50, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': ['catechol_A(92)', 'catechol', 'imine_1', 'Oxygen-nitrogen_single_bond', 'quaternary_nitrogen_2']}}
5. {'similarity score': 0.71, 'Rdkit information': {'Molecular Weight': 588.67, 'LogP': -1.97, 'Molecular Refractivity': 151.75, 'TPSA': 235.91, 'Hydrogen Bond_Donors': 8, 'Hydrogen_Bond Acceptors': 7, 'Rotatable Bonds': 9, 'Chiral Centers': 4, 'Heavy Atoms': 42, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': ['Aliphatic_long_chain', 'imine_1', 'imine_2']}}

## Discussion

The similarity scores indicate that compound X is most similar to the approved molecule 1 with a similarity score of 0.88. This suggests that the molecular structure of compound X shares similarities with the structure of the approved molecule 1. However, we must also consider the presence of structural alerts.

Structural alerts are potential issues with the molecular structure that could affect its pharmacokinetic or pharmacodynamic properties, leading to issues during regulatory approval. In this case, both compound X and its most similar approved molecule have the structural alert 'Aliphatic_long_chain'. Additionally, compound X has another structural alert 'disulphide'.

Furthermore, considering the non-approved molecules, the model identified several compounds with high similarity scores but none of them have been approved, which indicates that our compound may have similar structural issues or other liabilities that would prevent approval.

## Conclusion

Based on the analysis, the likelihood of compound X receiving regulatory approval is moderate. The similarity to approved small molecules is high, but we must consider the structural alerts present in both the compound itself and its similar molecules.

**Likelihood of approval: 60%**

Reason: Similarity to approved small molecules is high, but structural alerts and the presence of non-approved similar molecules suggest potential liabilities that could affect regulatory approval.

**Recommendation: Further analysis and optimization of the compound is required to address potential liabilities and improve its pharmacokinetic and pharmacodynamic properties.** 
Extracted:
## Analysis

To determine the likelihood of compound X receiving regulatory approval, we will analyze its similarity to both approved and non-approved small molecules.

### Similarity to Approved Small Molecules

The model has identified the top 5 most similar approved small molecules to compound X, with their respective similarity scores:

1. {'similarity score': 0.88, 'Rdkit information': {'Molecular Weight': 1500.55, 'LogP': -7.76, 'Molecular Refractivity': 364.76, 'TPSA': 505.95, 'Hydrogen Bond_Donors': 14, 'Hydrogen_Bond Acceptors': 25, 'Rotatable Bonds': 26, 'Chiral Centers': 10, 'Heavy Atoms': 101, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': ['Aliphatic_long_chain', 'disulphide']}}
2. {'similarity score': 0.78, 'Rdkit information': {'Molecular Weight': 1394.59, 'LogP': -3.4, 'Molecular Refractivity': 355.87, 'TPSA': 494.22, 'Hydrogen Bond_Donors': 17, 'Hydrogen_Bond Acceptors': 21, 'Rotatable Bonds': 34, 'Chiral Centers': 10, 'Heavy Atoms': 97, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': ['Aliphatic_long_chain', 'disulphide']}}
3. {'similarity score': 0.77, 'Rdkit information': {'Molecular Weight': 511.51, 'LogP': -3.37, 'Molecular Refractivity': 120.12, 'TPSA': 225.76, 'Hydrogen Bond_Donors': 5, 'Hydrogen_Bond Acceptors': 12, 'Rotatable Bonds': 10, 'Chiral Centers': 1, 'Heavy Atoms': 35, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['aldehyde']}}
4. {'similarity score': 0.73, 'Rdkit information': {'Molecular Weight': 473.45, 'LogP': -0.73, 'Molecular Refractivity': 120.78, 'TPSA': 219.84, 'Hydrogen Bond_Donors': 7, 'Hydrogen_Bond Acceptors': 9, 'Rotatable Bonds': 10, 'Chiral Centers': 1, 'Heavy Atoms': 34, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['aldehyde']}}
5. {'similarity score': 0.72, 'Rdkit information': {'Molecular Weight': 681.75, 'LogP': -4.68, 'Molecular Refractivity': 119.85, 'TPSA': 213.94, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 12, 'Rotatable Bonds': 20, 'Chiral Centers': 1, 'Heavy Atoms': 38, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': 'None'}}

### Similarity to Non-Approved Small Molecules

The model has identified the top 5 most similar non-approved small molecules to compound X, with their respective similarity scores:

1. {'similarity score': 0.89, 'Rdkit information': {'Molecular Weight': 1609.57, 'LogP': -7.38, 'Molecular Refractivity': 359.0, 'TPSA': 505.95, 'Hydrogen Bond_Donors': 14, 'Hydrogen_Bond Acceptors': 25, 'Rotatable Bonds': 26, 'Chiral Centers': 10, 'Heavy Atoms': 101, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': ['Aliphatic_long_chain', 'disulphide']}}
2. {'similarity score': 0.75, 'Rdkit information': {'Molecular Weight': 573.67, 'LogP': -0.46, 'Molecular Refractivity': 150.45, 'TPSA': 199.95, 'Hydrogen Bond_Donors': 7, 'Hydrogen_Bond Acceptors': 8, 'Rotatable Bonds': 16, 'Chiral Centers': 3, 'Heavy Atoms': 40, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}
3. {'similarity score': 0.73, 'Rdkit information': {'Molecular Weight': 473.45, 'LogP': -0.73, 'Molecular Refractivity': 120.78, 'TPSA': 219.84, 'Hydrogen Bond_Donors': 7, 'Hydrogen_Bond Acceptors': 9, 'Rotatable Bonds': 10, 'Chiral Centers': 2, 'Heavy Atoms': 34, 'Formal Charge': 0, 'Total Rings': 3, 'Structural Alerts': ['aldehyde']}}
4. {'similarity score': 0.71, 'Rdkit information': {'Molecular Weight': 752.23, 'LogP': -0.18, 'Molecular Refractivity': 179.0, 'TPSA': 256.90, 'Hydrogen Bond_Donors': 6, 'Hydrogen_Bond Acceptors': 14, 'Rotatable Bonds': 13, 'Chiral Centers': 2, 'Heavy Atoms': 50, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': ['catechol_A(92)', 'catechol', 'imine_1', 'Oxygen-nitrogen_single_bond', 'quaternary_nitrogen_2']}}
5. {'similarity score': 0.71, 'Rdkit information': {'Molecular Weight': 588.67, 'LogP': -1.97, 'Molecular Refractivity': 151.75, 'TPSA': 235.91, 'Hydrogen Bond_Donors': 8, 'Hydrogen_Bond Acceptors': 7, 'Rotatable Bonds': 9, 'Chiral Centers': 4, 'Heavy Atoms': 42, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': ['Aliphatic_long_chain', 'imine_1', 'imine_2']}}

## Discussion

The similarity scores indicate that compound X is most similar to the approved molecule 1 with a similarity score of 0.88. This suggests that the molecular structure of compound X shares similarities with the structure of the approved molecule 1. However, we must also consider the presence of structural alerts.

Structural alerts are potential issues with the molecular structure that could affect its pharmacokinetic or pharmacodynamic properties, leading to issues during regulatory approval. In this case, both compound X and its most similar approved molecule have the structural alert 'Aliphatic_long_chain'. Additionally, compound X has another structural alert 'disulphide'.

Furthermore, considering the non-approved molecules, the model identified several compounds with high similarity scores but none of them have been approved, which indicates that our compound may have similar structural issues or other liabilities that would prevent approval.

## Conclusion

Based on the analysis, the likelihood of compound X receiving regulatory approval is moderate. The similarity to approved small molecules is high, but we must consider the structural alerts present in both the compound itself and its similar molecules.

**Likelihood of approval: 60%**

Reason: Similarity to approved small molecules is high, but structural alerts and the presence of non-approved similar molecules suggest potential liabilities that could affect regulatory approval.

**Recommendation: Further analysis and optimization of the compound is required to address potential liabilities and improve its pharmacokinetic and pharmacodynamic properties.**
Unsloth: Will smartly offload gradients to save VRAM!
  1%|          | 2/250 [06:30<13:54:56, 202.00s/it]                                                   {'loss': -0.0, 'grad_norm': 0.11270706355571747, 'learning_rate': 2.0000000000000002e-07, 'rewards/xmlcount_reward_func': -0.9747500419616699, 'rewards/soft_format_reward_func': 0.0, 'rewards/strict_format_reward_func': 0.0, 'rewards/int_reward_func': 0.0, 'rewards/correctness_reward_func': 0.0, 'reward': -0.9747500419616699, 'reward_std': 1.1263917684555054, 'completion_length': 789.5, 'kl': 0.0, 'epoch': 0.0}
  1%|          | 2/250 [06:30<13:54:56, 202.00s/it]-------------------- Question:

            I have developed a model that can predict the drug likelibility of compound X.
            This model outputs two lists:
            1. The five most similar approved small molecules (with their properties and similarity scores).
            2. The five most similar non-approved small molecules (with their properties and similarity scores).

            Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.

            - RDKit Analysis of Compound X:
            {'Molecular Weight': 448.45, 'LogP': 3.66, 'Molecular Refractivity': 111.28, 'TPSA': 97.12, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 8, 'Rotatable Bonds': 5, 'Chiral Centers': 1, 'Heavy Atoms': 32, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': 'None'}

            Using the provided data:
            {'most similar appoved drugs': {1: { 'similarity score': 0.8, 'Rdkit information': {'Molecular Weight': 522.58, 'LogP': 2.01, 'Molecular Refractivity': 127.75, 'TPSA': 138.44, 'Hydrogen Bond_Donors': 4, 'Hydrogen_Bond Acceptors': 11, 'Rotatable Bonds': 10, 'Chiral Centers': 6, 'Heavy Atoms': 36, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': 'None'}}, 2: { 'similarity score': 0.79, 'Rdkit information': {'Molecular Weight': 506.61, 'LogP': 4.94, 'Molecular Refractivity': 140.71, 'TPSA': 75.00, 'Hydrogen Bond_Donors': 1, 'Hydrogen_Bond Acceptors': 8, 'Rotatable Bonds': 7, 'Chiral Centers': 0, 'Heavy Atoms': 37, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.79, 'Rdkit information': {'Molecular Weight': 447.54, 'LogP': 2.97, 'Molecular Refractivity': 128.65, 'TPSA': 105.04, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 9, 'Rotatable Bonds': 5, 'Chiral Centers': 0, 'Heavy Atoms': 33, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': 'None'}}, 4: { 'similarity score': 0.77, 'Rdkit information': {'Molecular Weight': 489.93, 'LogP': 5.54, 'Molecular Refractivity': 124.03, 'TPSA': 91.92, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 7, 'Chiral Centers': 0, 'Heavy Atoms': 33, 'Formal Charge': 0, 'Total Rings': 4, 'Structural Alerts': 'None'}}, 5: { 'similarity score': 0.77, 'Rdkit information': {'Molecular Weight': 375.4, 'LogP': 1.98, 'Molecular Refractivity': 99.63, 'TPSA': 83.80, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 6, 'Rotatable Bonds': 4, 'Chiral Centers': 0, 'Heavy Atoms': 27, 'Formal Charge': 0, 'Total Rings': 4, 'Structural Alerts': 'None'}}}, 'most similar non appoved drugs': {1: { 'similarity score': 0.79, 'Rdkit information': {'Molecular Weight': 415.43, 'LogP': 3.75, 'Molecular Refractivity': 115.64, 'TPSA': 101.38, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 7, 'Rotatable Bonds': 5, 'Chiral Centers': 1, 'Heavy Atoms': 31, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': 'None'}}, 2: { 'similarity score': 0.78, 'Rdkit information': {'Molecular Weight': 560.65, 'LogP': 5.03, 'Molecular Refractivity': 156.83, 'TPSA': 85.52, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 6, 'Rotatable Bonds': 7, 'Chiral Centers': 0, 'Heavy Atoms': 41, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.77, 'Rdkit information': {'Molecular Weight': 573.68, 'LogP': 1.83, 'Molecular Refractivity': 152.15, 'TPSA': 179.64, 'Hydrogen Bond_Donors': 4, 'Hydrogen_Bond Acceptors': 12, 'Rotatable Bonds': 7, 'Chiral Centers': 0, 'Heavy Atoms': 40, 'Formal Charge': 0, 'Total Rings': 5, 'Structural Alerts': ['Sulfonic_acid_2']}}, 4: { 'similarity score': 0.77, 'Rdkit information': {'Molecular Weight': 461.51, 'LogP': 3.61, 'Molecular Refractivity': 124.64, 'TPSA': 116.13, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 8, 'Rotatable Bonds': 6, 'Chiral Centers': 1, 'Heavy Atoms': 34, 'Formal Charge': 0, 'Total Rings': 6, 'Structural Alerts': ['2-halo_pyridine']}}, 5: { 'similarity score': 0.77, 'Rdkit information': {'Molecular Weight': 396.5, 'LogP': 2.28, 'Molecular Refractivity': 111.78, 'TPSA': 92.63, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 7, 'Rotatable Bonds': 7, 'Chiral Centers': 1, 'Heavy Atoms': 29, 'Formal Charge': 0, 'Total Rings': 4, 'Structural Alerts': ['N_oxide', 'quaternary_nitrogen_1']}}}}
             
Answer:
<NOT APPROVED> 
Response:
### Analyzing the likelihood of compound X receiving regulatory approval

To assess the likelihood of compound X receiving regulatory approval, I will analyze the properties of the five most similar approved and non-approved drugs.

### Reasoning

1.  The known-approved drug with the highest similarity score (0.8) is quite similar to compound X in terms of properties. This approved drug has a similar molecular weight (522.58 g/mol vs 448.45 g/mol), logP (2.01 vs 3.66), and molecular refractivity (127.75 vs 111.28).
2.  The two approved drugs with the next highest similarity scores are also relatively similar to compound X in terms of properties, with slightly larger molecular weights and logP values.
3.  The most similar non-approved drugs have high similarity scores (0.79 and 0.78), but their molecular weights are significantly larger (415.43 g/mol and 560.65 g/mol), logP values are higher (3.75 and 5.03), and molecular refractivities are larger (115.64 and 156.83). These differences may indicate challenges in compound X's pharmacokinetics and pharmacodynamics.
4.  The structural alerts in the most similar non-approved drugs suggest potential issues, such as toxicity or poor absorption.

### Analysis

To predict the likelihood of compound X receiving regulatory approval, I will conclude that:

*   Based on its similarity to approved drugs, compound X has a high likelihood of approval.
*   However, considering the significant differences with similar non-approved drugs, there may be concerns about compound X's pharmacokinetics and pharmacodynamics.
*   A deeper analysis of these differences and potential risks is necessary to confirm compound X's potential as a drug candidate.

### Answer

Based on the analysis, I would estimate the likelihood of compound X receiving regulatory approval as follows:

*   Initial likelihood: 70%
*   After further analysis: 80% 
Extracted:
### Analyzing the likelihood of compound X receiving regulatory approval

To assess the likelihood of compound X receiving regulatory approval, I will analyze the properties of the five most similar approved and non-approved drugs.

### Reasoning

1.  The known-approved drug with the highest similarity score (0.8) is quite similar to compound X in terms of properties. This approved drug has a similar molecular weight (522.58 g/mol vs 448.45 g/mol), logP (2.01 vs 3.66), and molecular refractivity (127.75 vs 111.28).
2.  The two approved drugs with the next highest similarity scores are also relatively similar to compound X in terms of properties, with slightly larger molecular weights and logP values.
3.  The most similar non-approved drugs have high similarity scores (0.79 and 0.78), but their molecular weights are significantly larger (415.43 g/mol and 560.65 g/mol), logP values are higher (3.75 and 5.03), and molecular refractivities are larger (115.64 and 156.83). These differences may indicate challenges in compound X's pharmacokinetics and pharmacodynamics.
4.  The structural alerts in the most similar non-approved drugs suggest potential issues, such as toxicity or poor absorption.

### Analysis

To predict the likelihood of compound X receiving regulatory approval, I will conclude that:

*   Based on its similarity to approved drugs, compound X has a high likelihood of approval.
*   However, considering the significant differences with similar non-approved drugs, there may be concerns about compound X's pharmacokinetics and pharmacodynamics.
*   A deeper analysis of these differences and potential risks is necessary to confirm compound X's potential as a drug candidate.

### Answer

Based on the analysis, I would estimate the likelihood of compound X receiving regulatory approval as follows:

*   Initial likelihood: 70%
*   After further analysis: 80%
  1%|          | 3/250 [10:31<15:05:28, 219.95s/it]                                                   {'loss': 0.0, 'grad_norm': 0.11234413087368011, 'learning_rate': 4.0000000000000003e-07, 'rewards/xmlcount_reward_func': -2.468250036239624, 'rewards/soft_format_reward_func': 0.0, 'rewards/strict_format_reward_func': 0.0, 'rewards/int_reward_func': 0.0, 'rewards/correctness_reward_func': 0.0, 'reward': -2.468250036239624, 'reward_std': 1.9321012496948242, 'completion_length': 812.25, 'kl': 6.481877790065482e-06, 'epoch': 0.0}
  1%|          | 3/250 [10:31<15:05:28, 219.95s/it]-------------------- Question:

            I have developed a model that can predict the drug likelibility of compound X.
            This model outputs two lists:
            1. The five most similar approved small molecules (with their properties and similarity scores).
            2. The five most similar non-approved small molecules (with their properties and similarity scores).

            Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.

            - RDKit Analysis of Compound X:
            {'Molecular Weight': 197.19, 'LogP': 0.05, 'Molecular Refractivity': 49.09, 'TPSA': 103.78, 'Hydrogen Bond_Donors': 4, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 3, 'Chiral Centers': 1, 'Heavy Atoms': 14, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['catechol_A(92)', 'catechol']}

            Using the provided data:
            {'most similar appoved drugs': {1: { 'similarity score': 0.99, 'Rdkit information': {'Molecular Weight': 211.22, 'LogP': 0.44, 'Molecular Refractivity': 53.7, 'TPSA': 103.78, 'Hydrogen Bond_Donors': 4, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 3, 'Chiral Centers': 1, 'Heavy Atoms': 15, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['catechol_A(92)', 'catechol']}}, 2: { 'similarity score': 0.98, 'Rdkit information': {'Molecular Weight': 213.19, 'LogP': -0.46, 'Molecular Refractivity': 50.34, 'TPSA': 124.01, 'Hydrogen Bond_Donors': 5, 'Hydrogen_Bond Acceptors': 5, 'Rotatable Bonds': 3, 'Chiral Centers': 2, 'Heavy Atoms': 15, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['catechol_A(92)', 'catechol']}}, 3: { 'similarity score': 0.95, 'Rdkit information': {'Molecular Weight': 169.18, 'LogP': 0.09, 'Molecular Refractivity': 43.79, 'TPSA': 86.71, 'Hydrogen Bond_Donors': 4, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 2, 'Chiral Centers': 1, 'Heavy Atoms': 12, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['catechol_A(92)', 'catechol']}}, 4: { 'similarity score': 0.95, 'Rdkit information': {'Molecular Weight': 153.18, 'LogP': 0.6, 'Molecular Refractivity': 42.53, 'TPSA': 66.48, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 2, 'Chiral Centers': 0, 'Heavy Atoms': 11, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['catechol_A(92)', 'catechol']}}, 5: { 'similarity score': 0.94, 'Rdkit information': {'Molecular Weight': 226.23, 'LogP': -0.05, 'Molecular Refractivity': 56.84, 'TPSA': 115.81, 'Hydrogen Bond_Donors': 5, 'Hydrogen_Bond Acceptors': 5, 'Rotatable Bonds': 4, 'Chiral Centers': 1, 'Heavy Atoms': 16, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['catechol_A(92)', 'catechol', 'hydrazine', 'Oxygen-nitrogen_single_bond']}}}, 'most similar non appoved drugs': {1: { 'similarity score': 0.96, 'Rdkit information': {'Molecular Weight': 181.19, 'LogP': 0.35, 'Molecular Refractivity': 47.42, 'TPSA': 83.55, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 3, 'Chiral Centers': 1, 'Heavy Atoms': 13, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': 'None'}}, 2: { 'similarity score': 0.96, 'Rdkit information': {'Molecular Weight': 195.22, 'LogP': 0.74, 'Molecular Refractivity': 52.04, 'TPSA': 83.55, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 3, 'Chiral Centers': 1, 'Heavy Atoms': 14, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': 'None'}}, 3: { 'similarity score': 0.94, 'Rdkit information': {'Molecular Weight': 218.26, 'LogP': 1.13, 'Molecular Refractivity': 62.23, 'TPSA': 68.25, 'Hydrogen Bond_Donors': 2, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 3, 'Chiral Centers': 1, 'Heavy Atoms': 16, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}, 4: { 'similarity score': 0.92, 'Rdkit information': {'Molecular Weight': 373.45, 'LogP': 2.73, 'Molecular Refractivity': 103.28, 'TPSA': 99.02, 'Hydrogen Bond_Donors': 4, 'Hydrogen_Bond Acceptors': 5, 'Rotatable Bonds': 9, 'Chiral Centers': 2, 'Heavy Atoms': 27, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': 'None'}}, 5: { 'similarity score': 0.92, 'Rdkit information': {'Molecular Weight': 189.64, 'LogP': 1.02, 'Molecular Refractivity': 49.78, 'TPSA': 66.48, 'Hydrogen Bond_Donors': 3, 'Hydrogen_Bond Acceptors': 3, 'Rotatable Bonds': 2, 'Chiral Centers': 0, 'Heavy Atoms': 12, 'Formal Charge': 0, 'Total Rings': 1, 'Structural Alerts': ['catechol_A(92)', 'catechol']}}}}
             
Answer:
<APPROVED> 
Response:
reasoning:
In order to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules, we need to consider both the approved and non-approved molecule similarities.

First, let's calculate the average similarity score from the most similar approved drugs:
(0.99 + 0.98 + 0.95 + 0.95 + 0.94) / 5 ≈ 0.96.

Then, we can analyze the pharmacokinetic properties of the approved drugs. In general, for a compound to be approved, it should have a suitable balance of properties such as molecular weight, logP, and hydrogen bond acceptors.

Now let's examine the approved drugs' properties:
1. The molecular weights of the compounds range from 153.18 to 226.23. They are relatively close to the molecular weight of compound X (197.19), indicating that compound X is in the middle of the range.
2. The logP values of the approved drugs range from -0.46 to 1.13, which is also close to the logP value of compound X (0.05).
3. In terms of hydrogen bond acceptors, the approved drugs have 3 to 5 hydrogen bond acceptors, which is similar to the hydrogen bond acceptors of compound X (4).

While this suggests that compound X is similar to the approved drugs, we should also consider the non-approved drugs in our analysis.

The average similarity score from the most similar non-approved drugs is:
(0.96 + 0.96 + 0.94 + 0.92 + 0.92) / 5 ≈ 0.94.

For compound X to be approved, it should be similar to both approved and non-approved drugs. Therefore, compound X's reliance on the approved and non-approved drugs' properties can be assessed by combining their similarity scores.

answer:
Based on the analysis, the likelihood of compound X receiving regulatory approval is high (approximately 0.95), given its similarity to both approved and non-approved molecules. 
Extracted:
reasoning:
In order to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules, we need to consider both the approved and non-approved molecule similarities.

First, let's calculate the average similarity score from the most similar approved drugs:
(0.99 + 0.98 + 0.95 + 0.95 + 0.94) / 5 ≈ 0.96.

Then, we can analyze the pharmacokinetic properties of the approved drugs. In general, for a compound to be approved, it should have a suitable balance of properties such as molecular weight, logP, and hydrogen bond acceptors.

Now let's examine the approved drugs' properties:
1. The molecular weights of the compounds range from 153.18 to 226.23. They are relatively close to the molecular weight of compound X (197.19), indicating that compound X is in the middle of the range.
2. The logP values of the approved drugs range from -0.46 to 1.13, which is also close to the logP value of compound X (0.05).
3. In terms of hydrogen bond acceptors, the approved drugs have 3 to 5 hydrogen bond acceptors, which is similar to the hydrogen bond acceptors of compound X (4).

While this suggests that compound X is similar to the approved drugs, we should also consider the non-approved drugs in our analysis.

The average similarity score from the most similar non-approved drugs is:
(0.96 + 0.96 + 0.94 + 0.92 + 0.92) / 5 ≈ 0.94.

For compound X to be approved, it should be similar to both approved and non-approved drugs. Therefore, compound X's reliance on the approved and non-approved drugs' properties can be assessed by combining their similarity scores.

answer:
Based on the analysis, the likelihood of compound X receiving regulatory approval is high (approximately 0.95), given its similarity to both approved and non-approved molecules.
  2%|▏         | 4/250 [13:02<13:09:34, 192.58s/it]                                                   {'loss': 0.0, 'grad_norm': 0.15789176523685455, 'learning_rate': 6.000000000000001e-07, 'rewards/xmlcount_reward_func': -0.28325000405311584, 'rewards/soft_format_reward_func': 0.0, 'rewards/strict_format_reward_func': 0.0, 'rewards/int_reward_func': 0.0, 'rewards/correctness_reward_func': 0.0, 'reward': -0.28325000405311584, 'reward_std': 0.6524994969367981, 'completion_length': 462.75, 'kl': 1.0679237675503828e-05, 'epoch': 0.0}
  2%|▏         | 4/250 [13:02<13:09:34, 192.58s/it]slurmstepd: error: *** JOB 110387 ON en-7-1 CANCELLED AT 2025-04-10T19:00:17 ***
#################################################
Panthera Cluster
Job 110387 for user 'u111169'
Finished at: Thu Apr 10 19:00:21 +0330 2025
Job details file : ~/JobSummary/110387.out
================================================
